⌘K

Login Start Free

Home/Filings/4/0001213900-25-005966

4//SEC Filing

Fabbio Patrick 4

Accession 0001213900-25-005966

CIK 0001359931other

View on SEC.gov Company Profile

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:05 PM ET

Size

5.1 KB

Accession

0001213900-25-005966

Insider Transaction Report

Form 4

Period: 2025-01-21

Protara Therapeutics, Inc.TARA

Chief Financial Officer

Transactions

Tax Payment
Common Stock
2025-01-21$4.76/sh−3,061$14,570→ 18,939 total

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 19, 2024.

Documents

1 file

4
marketforms-67896.xmlPrimary
PRIMARY DOCUMENT

Issuer

Protara Therapeutics, Inc.

CIK 0001359931

Entity typeother

Related Parties

1

filerCIK 0001658859

Filing Metadata

Form type: 4
Filed: Jan 22, 7:00 PM ET
Accepted: Jan 23, 4:05 PM ET
Size: 5.1 KB

View on SEC.gov